The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma

• Jingsong He ,

  Contributed equally to this work with: Jingsong He, Li Yang

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Li Yang ,

  Contributed equally to this work with: Jingsong He, Li Yang

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Xiaoyan Han,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Gaofeng Zheng,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Weiyan Zheng,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Guoqing Wei,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Wenjun Wu,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Xiujin Ye,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Jimin Shi,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Wanzhuo Xie,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Li Li,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Jie Zhang,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Weijia Huang,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Yi Zhao,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• He Huang,

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• Xuejin Zhang,

  Affiliation Department of Hematology, Red Cross Hospital in Hangzhou, Zhejiang, P. R. China

  ⨯
• Jiaping Fu,

  Affiliation Department of Hematology, Shaoxing People’s Hospital, Zhejiang, P. R. China

  ⨯
•  [ ... ],
• Zhen Cai

  * E-mail: caiz@zju.edu.cn

  Affiliation The Bone Marrow Transplantation center & Multiple Myeloma Treatment Center, The First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou, Zhejiang, P. R. China

  ⨯
• [ view all ]
• [ view less ]